HEADER HYDROLASE 14-SEP-07 2RA0 TITLE X-RAY STRUCTURE OF FXA IN COMPLEX WITH 7-FLUOROINDAZOLE COMPND MOL_ID: 1; COMPND 2 MOLECULE: COAGULATION FACTOR X; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: HEAVY CHAIN, UNP RESIDUES 235-468; COMPND 5 SYNONYM: STUART FACTOR, STUART-PROWER FACTOR; COMPND 6 EC: 3.4.21.6; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: COAGULATION FACTOR X; COMPND 10 CHAIN: L; COMPND 11 FRAGMENT: LIGHT CHAIN, UNP RESIDUES 128-178; COMPND 12 SYNONYM: STUART FACTOR, STUART-PROWER FACTOR; COMPND 13 EC: 3.4.21.6; COMPND 14 ENGINEERED: YES; COMPND 15 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: F10; SOURCE 6 EXPRESSION_SYSTEM_STRAIN: HEK293EBNA; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PCEP4; SOURCE 9 OTHER_DETAILS: MAMMALIAN; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 GENE: F10; SOURCE 15 EXPRESSION_SYSTEM_STRAIN: HEK293EBNA; SOURCE 16 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 17 EXPRESSION_SYSTEM_PLASMID: PCEP4; SOURCE 18 OTHER_DETAILS: MAMMALIAN KEYWDS SERINE PROTEASE, BLOOD COAGULATION, CALCIUM, CLEAVAGE ON PAIR OF KEYWDS 2 BASIC RESIDUES, EGF-LIKE DOMAIN, GAMMA-CARBOXYGLUTAMIC ACID, KEYWDS 3 GLYCOPROTEIN, HYDROLASE, HYDROXYLATION, POLYMORPHISM, ZYMOGEN EXPDTA X-RAY DIFFRACTION AUTHOR M.C.ABAD REVDAT 3 20-OCT-21 2RA0 1 REMARK SEQADV REVDAT 2 24-FEB-09 2RA0 1 VERSN REVDAT 1 29-JAN-08 2RA0 0 JRNL AUTH Y.K.LEE,D.J.PARKS,T.LU,T.V.THIEU,T.MARKOTAN,W.PAN, JRNL AUTH 2 D.F.MCCOMSEY,K.L.MILKIEWICZ,C.S.CRYSLER,N.NINAN,M.C.ABAD, JRNL AUTH 3 E.C.GIARDINO,B.E.MARYANOFF,B.P.DAMIANO,M.R.PLAYER JRNL TITL 7-FLUOROINDAZOLES AS POTENT AND SELECTIVE INHIBITORS OF JRNL TITL 2 FACTOR XA. JRNL REF J.MED.CHEM. V. 51 282 2008 JRNL REFN ISSN 0022-2623 JRNL PMID 18159923 JRNL DOI 10.1021/JM701217R REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 53.06 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.7 REMARK 3 NUMBER OF REFLECTIONS : 12612 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.246 REMARK 3 FREE R VALUE : 0.314 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.200 REMARK 3 FREE R VALUE TEST SET COUNT : 1303 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2228 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 39 REMARK 3 SOLVENT ATOMS : 81 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.24 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 9.06100 REMARK 3 B22 (A**2) : 9.61400 REMARK 3 B33 (A**2) : -18.67500 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : NULL REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.487 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.516 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.804 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.634 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : MSI_CNX_TOPPAR:PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : INH.PAR REMARK 3 PARAMETER FILE 3 : MSI_CNX_TOPPAR:WATER_REP.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2RA0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-SEP-07. REMARK 100 THE DEPOSITION ID IS D_1000044611. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-APR-04 REMARK 200 TEMPERATURE (KELVIN) : 200 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : BRUKER AXS MICROSTAR REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : BRUKER SMART 6000 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : SAINT REMARK 200 DATA SCALING SOFTWARE : SAINT V7.03A REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12708 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 74.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 7.050 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.10700 REMARK 200 FOR THE DATA SET : 29.3050 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.6 REMARK 200 DATA REDUNDANCY IN SHELL : 6.92 REMARK 200 R MERGE FOR SHELL (I) : 0.07130 REMARK 200 R SYM FOR SHELL (I) : 0.24500 REMARK 200 FOR SHELL : 2.070 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.97 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.16 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20%PEG 3350, 10MM CACL2, 0.1M TRIS REMARK 280 -MALEATE PH 5.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 24.43550 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 37.54450 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.49200 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 37.54450 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.43550 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 37.49200 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1640 ANGSTROM**2 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, L REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 61A 10.55 -165.32 REMARK 500 LYS A 62 -84.19 56.02 REMARK 500 GLU A 77 -87.05 32.40 REMARK 500 GLU A 80 -173.78 -60.49 REMARK 500 ILE A 89 79.52 -116.09 REMARK 500 ARG A 115 -167.86 -178.34 REMARK 500 SER A 195 140.39 -32.49 REMARK 500 ASP A 205 19.86 58.94 REMARK 500 SER A 214 -70.40 -112.70 REMARK 500 ARG A 222 -169.07 -70.12 REMARK 500 LYS A 243 93.07 67.66 REMARK 500 GLN L 98 -108.67 -131.48 REMARK 500 LYS L 122 -60.77 -120.96 REMARK 500 TYR L 130 70.03 -118.21 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE JNJ A 1 DBREF 2RA0 A 16 244 UNP P00742 FA10_HUMAN 235 468 DBREF 2RA0 L 88 138 UNP P00742 FA10_HUMAN 128 178 SEQADV 2RA0 VAL L 88 UNP P00742 LEU 128 ENGINEERED MUTATION SEQRES 1 A 234 ILE VAL GLY GLY GLN GLU CYS LYS ASP GLY GLU CYS PRO SEQRES 2 A 234 TRP GLN ALA LEU LEU ILE ASN GLU GLU ASN GLU GLY PHE SEQRES 3 A 234 CYS GLY GLY THR ILE LEU SER GLU PHE TYR ILE LEU THR SEQRES 4 A 234 ALA ALA HIS CYS LEU TYR GLN ALA LYS ARG PHE LYS VAL SEQRES 5 A 234 ARG VAL GLY ASP ARG ASN THR GLU GLN GLU GLU GLY GLY SEQRES 6 A 234 GLU ALA VAL HIS GLU VAL GLU VAL VAL ILE LYS HIS ASN SEQRES 7 A 234 ARG PHE THR LYS GLU THR TYR ASP PHE ASP ILE ALA VAL SEQRES 8 A 234 LEU ARG LEU LYS THR PRO ILE THR PHE ARG MET ASN VAL SEQRES 9 A 234 ALA PRO ALA CYS LEU PRO GLU ARG ASP TRP ALA GLU SER SEQRES 10 A 234 THR LEU MET THR GLN LYS THR GLY ILE VAL SER GLY PHE SEQRES 11 A 234 GLY ARG THR HIS GLU LYS GLY ARG GLN SER THR ARG LEU SEQRES 12 A 234 LYS MET LEU GLU VAL PRO TYR VAL ASP ARG ASN SER CYS SEQRES 13 A 234 LYS LEU SER SER SER PHE ILE ILE THR GLN ASN MET PHE SEQRES 14 A 234 CYS ALA GLY TYR ASP THR LYS GLN GLU ASP ALA CYS GLN SEQRES 15 A 234 GLY ASP SER GLY GLY PRO HIS VAL THR ARG PHE LYS ASP SEQRES 16 A 234 THR TYR PHE VAL THR GLY ILE VAL SER TRP GLY GLU GLY SEQRES 17 A 234 CYS ALA ARG LYS GLY LYS TYR GLY ILE TYR THR LYS VAL SEQRES 18 A 234 THR ALA PHE LEU LYS TRP ILE ASP ARG SER MET LYS THR SEQRES 1 L 51 VAL CYS SER LEU ASP ASN GLY ASP CYS ASP GLN PHE CYS SEQRES 2 L 51 HIS GLU GLU GLN ASN SER VAL VAL CYS SER CYS ALA ARG SEQRES 3 L 51 GLY TYR THR LEU ALA ASP ASN GLY LYS ALA CYS ILE PRO SEQRES 4 L 51 THR GLY PRO TYR PRO CYS GLY LYS GLN THR LEU GLU HET JNJ A 1 39 HETNAM JNJ 1-(3-AMINO-1,2-BENZISOXAZOL-5-YL)-6-(4-{2- HETNAM 2 JNJ [(DIMETHYLAMINO)METHYL]-1H-IMIDAZOL-1-YL}-2- HETNAM 3 JNJ FLUOROPHENYL)-7-FLUORO-1H-INDAZOLE-3-CARBOXAMIDE HETSYN JNJ 1-(3-AMINOBENZO[D]ISOXAZOL-5-YL)-6-[4-(2- HETSYN 2 JNJ DIMETHYLAMINOMETHYLIMIDAZOL-1-YL)-2-FLUOROPHENYL]-7- HETSYN 3 JNJ FLUORO-1H-INDAZOLE-3-CARBOXYLIC ACID AMIDE FORMUL 3 JNJ C27 H22 F2 N8 O2 FORMUL 4 HOH *81(H2 O) HELIX 1 1 ALA A 55 LEU A 59 5 5 HELIX 2 2 GLU A 124A LEU A 131A 1 9 HELIX 3 3 ASP A 164 SER A 172 1 9 HELIX 4 4 PHE A 234 MET A 242 1 9 HELIX 5 5 LEU L 91 CYS L 96 5 6 SHEET 1 A 8 GLN A 20 GLU A 21 0 SHEET 2 A 8 LYS A 156 VAL A 163 -1 O MET A 157 N GLN A 20 SHEET 3 A 8 MET A 180 ALA A 183 -1 O CYS A 182 N VAL A 163 SHEET 4 A 8 GLY A 226 LYS A 230 -1 O TYR A 228 N PHE A 181 SHEET 5 A 8 THR A 206 TRP A 215 -1 N TRP A 215 O ILE A 227 SHEET 6 A 8 PRO A 198 PHE A 203 -1 N HIS A 199 O THR A 210 SHEET 7 A 8 THR A 135 GLY A 140 -1 N ILE A 137 O VAL A 200 SHEET 8 A 8 LYS A 156 VAL A 163 -1 O LEU A 158 N VAL A 138 SHEET 1 B 7 GLN A 30 ILE A 34 0 SHEET 2 B 7 GLY A 40 ILE A 46 -1 O CYS A 42 N LEU A 33 SHEET 3 B 7 TYR A 51 THR A 54 -1 O LEU A 53 N THR A 45 SHEET 4 B 7 ALA A 104 LEU A 108 -1 O ALA A 104 N THR A 54 SHEET 5 B 7 ALA A 81 LYS A 90 -1 N GLU A 86 O ARG A 107 SHEET 6 B 7 LYS A 65 VAL A 68 -1 N VAL A 66 O HIS A 83 SHEET 7 B 7 GLN A 30 ILE A 34 -1 N ILE A 34 O LYS A 65 SHEET 1 C 2 PHE L 99 GLU L 103 0 SHEET 2 C 2 SER L 106 SER L 110 -1 O VAL L 108 N HIS L 101 SHEET 1 D 2 TYR L 115 LEU L 117 0 SHEET 2 D 2 CYS L 124 PRO L 126 -1 O ILE L 125 N THR L 116 SSBOND 1 CYS A 22 CYS A 27 1555 1555 2.83 SSBOND 2 CYS A 42 CYS A 58 1555 1555 2.67 SSBOND 3 CYS A 122 CYS L 132 1555 1555 2.43 SSBOND 4 CYS A 168 CYS A 182 1555 1555 2.67 SSBOND 5 CYS A 191 CYS A 220 1555 1555 2.67 SSBOND 6 CYS L 89 CYS L 100 1555 1555 2.47 SSBOND 7 CYS L 96 CYS L 109 1555 1555 2.46 SSBOND 8 CYS L 111 CYS L 124 1555 1555 2.44 SITE 1 AC1 16 LYS A 96 GLU A 97 THR A 98 TYR A 99 SITE 2 AC1 16 GLU A 146 ASP A 189 ALA A 190 CYS A 191 SITE 3 AC1 16 GLN A 192 SER A 195 VAL A 213 TRP A 215 SITE 4 AC1 16 GLY A 216 GLY A 218 CYS A 220 GLY A 226 CRYST1 48.871 74.984 75.089 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020462 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013336 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013318 0.00000